Publications by authors named "Andy Barker"

Claim this Profile
E
Expanding medicinal chemistry space.
Andy Barker, Jason G Kettle, Thorsten Nowak, J Elizabeth Pease

Drug Discov Today· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts.
Kate F Byth, Andrew Thomas, Gareth Hughes, Cheryl Forder, Alexandra McGregor, Andy Barker

Mol Cancer Ther· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imidazoles: SAR and development of a potent class of cyclin-dependent kinase inhibitors.
Malcolm Anderson, David M Andrews, Andy J Barker, Claire A Brassington, Jason Breed

Bioorg Med Chem Lett· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-Benzylindole-2-carboxylic acids: potent functional antagonists of the CCR2b chemokine receptor.
Jason G Kettle, Alan W Faull, Andy J Barker, D Huw Davies, Michael A Stone

Bioorg Med Chem Lett· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis